Who We Are
Flatiron Health is a pioneering healthtech company with a mission to improve and extend lives by learning from the experience of every person with cancer. They believe that this learning process is crucial for accelerating research and enhancing the quality of care in oncology. Their vision is to bridge the gap between care and research using technology and science.
What We Do
Flatiron Health provides technology and services to support patient care and ensure that every individual's story counts in the fight against cancer. They partner with hundreds of cancer centers, top global developers of oncology therapeutics, and researchers and regulators worldwide. With a focus on real-world evidence for oncology, Flatiron Health is dedicated to advancing research and improving cancer treatment.
Our Story
Founded in 2012, Flatiron Health has been a trailblazer in real-world evidence for oncology. In 2018, they became an independent affiliate of the Roche Group. Under the leadership of CEO Carolyn Starrett, Flatiron Health has expanded its commitment to advancing research and treatment globally. Their international subsidiaries in Japan, Germany, and the United Kingdom collaborate with local healthcare providers to meet each market's specific needs and requirements.
Our Team
Flatiron Health's team comprises passionate individuals from diverse backgrounds who work together to solve meaningful problems in oncology. They have an Executive Team and a Medical Team that drive the company's mission forward through problem-solving and innovation.
Commitment to Diversity, Equity, and Inclusion
At Flatiron Health, diversity, equity, and inclusion are core values. They strive to create an inclusive environment where diverse perspectives contribute to transforming cancer care. The company is dedicated to elevating voices, celebrating differences, and fostering a sense of belonging among its employees.
Transforming Global Oncology Research and Care
Flatiron Health is at the forefront of accelerating cancer research and enhancing the quality of care on a global scale. By leveraging real-world evidence, they improve patient outcomes, inform policy decisions, and advance oncology research. The company's commitment to data confidentiality ensures that patient information is protected with robust standards.